Free Trial

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors

GBX 16.41 +0.27 (+1.69%)
(As of 12/20/2024 ET)

CYBG vs. CCFS, CIHL, IL0A, JEO, OCI, AGT.LN, AFX, JESC, SLPE, and BGSC

Should you be buying VanEck Bionic Engineering UCITS ETF A Acc stock or one of its competitors? The main competitors of VanEck Bionic Engineering UCITS ETF A Acc include Charter Court Financial Services Grp (CCFS), Caribbean Investment (CIHL), Permanent TSB Group (IL0A), European Opportunities Trust (JEO), Oakley Capital Investments (OCI), AVI Global Trust (AGT.LN), Alpha FX Group (AFX), JPMorgan European Smaller Companies Trust (JESC), Standard Life Private Equity Trust (SLPE), and BMO Global Smaller Companies (BGSC).

VanEck Bionic Engineering UCITS ETF A Acc vs.

VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Charter Court Financial Services Grp (LON:CCFS) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations, community ranking and risk.

VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Charter Court Financial Services Grp pays an annual dividend of GBX 0.09 per share. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Charter Court Financial Services Grp pays out 0.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled Charter Court Financial Services Grp'saverage media sentiment score.

VanEck Bionic Engineering UCITS ETF A Acc received 104 more outperform votes than Charter Court Financial Services Grp when rated by MarketBeat users. However, 73.88% of users gave Charter Court Financial Services Grp an outperform vote while only 50.88% of users gave VanEck Bionic Engineering UCITS ETF A Acc an outperform vote.

CompanyUnderperformOutperform
VanEck Bionic Engineering UCITS ETF A AccOutperform Votes
203
50.88%
Underperform Votes
196
49.12%
Charter Court Financial Services GrpOutperform Votes
99
73.88%
Underperform Votes
35
26.12%

Company Net Margins Return on Equity Return on Assets
VanEck Bionic Engineering UCITS ETF A AccN/A N/A N/A
Charter Court Financial Services Grp N/A N/A N/A

VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Charter Court Financial Services Grp, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc£1.24B0.19N/A-£7.10-2.31
Charter Court Financial Services Grp£221.10M0.00N/A£46.30N/A

Summary

VanEck Bionic Engineering UCITS ETF A Acc beats Charter Court Financial Services Grp on 4 of the 7 factors compared between the two stocks.

Get VanEck Bionic Engineering UCITS ETF A Acc News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYBG and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYBG vs. The Competition

MetricVanEck Bionic Engineering UCITS ETF A AccBanks IndustryFinance SectorLON Exchange
Market Cap£235.37M£235.37M£11.30B£1.90B
Dividend Yield2.25%2.25%5.65%5.55%
P/E Ratio-2.31N/A26.721,821.81
Price / Sales0.1919.0134.97386,342.76
Price / Cash0.130.1318.7328.54
Price / Book0.050.052.612.78
Net IncomeN/AN/A£1.04B£157.16M
7 Day Performance-0.60%-0.12%-2.91%-2.00%
1 Month Performance-2.13%-0.43%-3.48%21.23%
1 Year Performance1.22%0.24%10.96%29.20%

VanEck Bionic Engineering UCITS ETF A Acc Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYBG
VanEck Bionic Engineering UCITS ETF A Acc
N/AGBX 16.41
+1.7%
N/A+2.0%£235.37M£1.24B-2.315,762
CCFS
Charter Court Financial Services Grp
N/AGBX 295
+3.7%
N/AN/A£713.62M£221.10M6.37676Gap Up
CIHL
Caribbean Investment
N/AGBX 26.50
flat
N/AN/A£35.27M£29.20M3.08N/AGap Up
High Trading Volume
IL0A
Permanent TSB Group
N/AGBX 2.38
flat
N/AN/A£12.99M£406M5.532,236
JEO
European Opportunities Trust
N/AGBX 843
-2.4%
N/AN/A£886.70M£-62,326,000.00-12.93N/A
OCI
Oakley Capital Investments
N/AGBX 502
flat
N/A+1.2%£885.63M£99.09M1,004.00N/AInsider Trade
News Coverage
Positive News
AGT.LN
AVI Global Trust
N/AN/AN/AN/A£812.93M£51.62M20.82N/AHigh Trading Volume
AFX
Alpha FX Group
N/AGBX 1,920
-0.5%
N/AN/A£810.18M£89.43M3,200.00214
JESC
JPMorgan European Smaller Companies Trust
N/AGBX 499
-1.0%
N/AN/A£795.72M£114.05M7.60N/APositive News
SLPE
Standard Life Private Equity Trust
N/AGBX 512
-1.5%
N/A+18.3%£787.18M£251.60M3.30N/A
BGSC
BMO Global Smaller Companies
N/AGBX 140.60
-0.8%
N/AN/A£769.56M£303.85M2.77N/A

Related Companies and Tools


This page (LON:CYBG) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners